ArticlePharmaceuticals (Basel, Switzerland)2022

Hybrid Approach to Identifying Druglikeness Leading Compounds against COVID-19 3CL Protease.

Imra Aqeel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.